Cardio Care Live

CME Presentations

PCSK9


Presentations


Speakers

  • Jennifer G. Robinson, MD, MPH

    Jennifer G. Robinson, MD, MPH

    Jennifer G. Robinson, MD, MPH

    Professor, Departments of Epidemiology & Medicine

    Jennifer G. Robinson, MD, MPH, is a professor in the Departments of Epidemiology & Medicine, and is the director of the Prevention Intervention Center in the Department of Epidemiology at the University of Iowa College of Public Health and University of Iowa Hospitals and Clinics in Iowa City. She earned her medical and master of public health degrees from the University of Minnesota School of Medicine and School of Public Health, respectively. Dr Robinson is widely published in her field in such publications as JAMA, American Heart Journal, European Heart Journal, Journal of the American Heart Association, and Circulation, among others.
  • Karol Watson, MD, PhD

    Karol Watson, MD, PhD

    Karol Watson, MD, PhD

    Professor of Medicine/Cardiology

    Karol Watson, MD, PhD, is an attending cardiologist and a professor of medicine/cardiology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). She is the director of the UCLA Women’s Cardiovascular Health Center, the UCLA-Barbra Streisand Women’s Heart Health Program, the co-director of the UCLA Program in Preventive Cardiology, and the director of the UCLA Fellowship Program in Cardiovascular Diseases. She is a principal investigator for several large National Institutes of Health research studies, a fellow of the American College of Cardiology and a member of the American Heart Association. She is a board member of the American Heart Association, Western States Affiliate, and chairperson of the Scientific Advisory Board for Womenheart.
  • Norman E. Lepor, MD

    Norman E. Lepor, MD

    Norman E. Lepor, MD

    Clinical Professor of Medicine

    Norman E. Lepor, MD, FACC, FAHA, FSCAI, earned his MD at Johns Hopkins University School of Medicine in Baltimore, Maryland, and completed his postdoctoral training in cardiology at Cedars-Sinai Medical Center in Los Angeles, California. He is board-certified in internal medicine and cardiovascular diseases by the American Board of Internal Medicine, and is a co-founder of Westside Medical Imaging/Westside Medical Associates of Los Angeles. Dr Lepor is regarded as a national authority in the treatment of hypertension, lipid disorders, heart failure, diabetic heart disease, peripheral vascular disease, and arrhythmias. He has been a primary investigator in several pivotal clinical trials and has written extensively in journals that include JAMA and the American Journal of Cardiology.
  • Alan S. Brown, MD

    Alan S. Brown, MD

    Alan S. Brown, MD

    Clinical Associate Professor

    Alan S. Brown, MD, is the director of the Prevention Center/Lipid Clinic for Midwest Heart Specialists and a clinical associate professor of medicine and cardiology at Loyola Stritch School of Medicine. He is the director of the Division of Cardiology at Advocate Lutheran General Hospital in Park Ridge, Illinois, and is a fellow of the American Heart Association, the National Lipid Association, and the American College of Cardiology. Dr Brown serves on the ACC Task Force for Appropriate Use Criteria, the Board of Directors for the National Lipid Association and the NLA Foundation, is a past president of the Midwest Chapter of the National Lipid Association, and serves on the Board of Directors of the American Society for Preventative Cardiology.
  • Eli M. Roth, MD

    Eli M. Roth, MD

    Eli M. Roth, MD

    President

    Eli M. Roth, MD, is the medical director of Sterling Research Group in Cincinnati, Oho. Board-certified in internal medicine, cardiovascular disease and clinical lipidology, he has more than 24 years of experience in general and interventional cardiology. Dr Roth is currently a professor of clinical medicine and Director of Preventive Cardiology for the Division of Cardiology at the University of Cincinnati College of Medicine. He has more than 12 years of experience in clinical trials and has been principal investigator or sub-investigator on over 500 clinical trials. Dr Roth also has ACRP/APPI certification as a Certified Principal Investigator.

CME Information

NONSTATIN DECISION MAKING TO DECREASE CARDIOVASCULAR RISK


   

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Define the high- and very-high-risk patient types who remain at risk for a cardiovascular (CV) event despite access to conventional lipid-lowering therapy and explore the possibilities of a new or expanded algorithm
  • Review current lipid guidelines and consensus documents. Explain whether recent clinical trial results point to low-density lipoprotein cholesterol (LDL-C) reduction goals be absolute, percentage-based, or a combination depending on patient presentation
  • Describe the most current outcome trial data on PCSK9 inhibitors exploring the effects on CV effects and how they affect safety concerns
  • Review efficacy and safety findings from PCSK9 inhibitor trials relating to a patient’s baseline CV risk, LDL-C level and achievement of very low LDL-C levels
  • Review the most recent decision pathways and anticipate the results of the ODYSSEY OUTCOME trial based on the results of recently published outcome trials and their trial designs
  • Discuss the current climate of payer willingness to support the use of PCSK9 inhibitors. Define the higher CV risk patient and how best to support their access to PCSK9i treatment

Acknowledgement

This activity is supported by an independent educational grant from sanofi-aventis, U.S. and Regeneron Pharmaceuticals.

Tuition

Complimentary

Accreditation Statement

The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and MRCME. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statements

Physician Continuing Education
Live Internet Activity

Albert Einstein College of Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

The American Academy of Nurse Practitioners (AANP) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

Date of Releasae/Expiration

Live Activity
Wednesday, February 28, 2018 from 12:00 PM EST–1:30 PM EST

Intended Audience

This educational activity is designed to meet the needs of cardiologists treating patients with dyslipidemia.

Estimated Time to Complete

This activity consists of one session, which should take approximately 1.5 hours to complete.

Method of Participation

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 1.5 hour to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the posttest.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Faculty Disclosure

The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

Financial Disclosures

Presenters

Norman E. Lepor, MD

Consultant: Amgen, Regeneron, Sanofi
Speakers Bureau: Amgen, Regeneron, Sanofi
Research Grants to Institution: Regeneron

Jennifer G. Robinson, MD, MPh

Research Grants to Institution: Amarin, Amgen, Astra-Zeneca, Esai, Esperion, Merck, Pfizer, Regeneron, Sanofi, Takeda
Consultant: Amgen, Eli Lilly, Merck, Pfizer, Regeneron, Sanofi

Alan S. Brown, MD

Consultant: Akcea, Amgen, Kastle, Kowa, Merck, Regeneron, Sanofi Speakers Bureau: Amgen, Regeneron, Sanofi

Eli M. Roth, MD

Consultant : Sanofi
Speakers Bureau: Amgen, Regeneron, Sanofi
Honoraria: Regeneron, Sanofi

Karol Watson, MD, PhD

Consultant : Amgen, Boehringer Ingelheim
Speakers Bureau : Boehringer Ingelheim

Peer Reviewer

Victor B. Hatcher, PhD

Has nothing to disclose relevant to this activity.

Providers

Einstein-Montefiore Center for Continuing Medical Education

The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity.

MRCME

The staff at MRCME has nothing to disclose relevant to this activity.

Content Development

Merilee Croft, MRCME

Has nothing to disclose relevant to this activity.

Discalimer (if applicable)

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine, MRCME, CardioCareLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Contact Information

Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.

For issues with your CME Certificate, please contact NeuroSeriesLive or PsychiatryCareLive at 877-394-1306 or at Support@CardioCareLive.com.